1. Li, Li, Situ, Hui-Jing, Ma, Wen-Cheng, Liu, Xuan, Wang, Lu-Lu. 2021. Decreased DHRS1 expression is a novel predictor of poor survival in patients with hepatocellular carcinoma. In Biomarkers in medicine, 15, 1319-1331. doi:10.2217/bmm-2021-0041. https://pubmed.ncbi.nlm.nih.gov/34498498/
2. Ye, Jiazhou, Lin, Yan, Gao, Xing, Li, Yongqiang, Liang, Rong. 2022. Prognosis-Related Molecular Subtypes and Immune Features Associated with Hepatocellular Carcinoma. In Cancers, 14, . doi:10.3390/cancers14225721. https://pubmed.ncbi.nlm.nih.gov/36428813/
3. Wu, Q, Xu, M, Cheng, C, Xie, Y, Mao, Y. . Molecular cloning and characterization of a novel Dehydrogenase/reductase (SDR family) member 1 genea from human fetal brain. In Molecular biology reports, 28, 193-8. doi:. https://pubmed.ncbi.nlm.nih.gov/12153138/
4. Shibata, Tatsuhiro, Kokubu, Akiko, Miyamoto, Masashi, Sasajima, Yuko, Yamazaki, Naoya. . Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation. In The American journal of pathology, 178, 1395-402. doi:10.1016/j.ajpath.2010.12.011. https://pubmed.ncbi.nlm.nih.gov/21356389/